Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) just unveiled an announcement.
Zylox-Tonbridge Medical Technology Co., Ltd. has granted 250,000 awards under its Share Award Scheme to a service provider involved in consultancy services related to the company’s product development. This grant aims to recognize and motivate the service provider, aligning their interests with the company’s long-term growth objectives. The awards are subject to performance targets and a clawback mechanism, ensuring alignment with the company’s strategic goals.
The most recent analyst rating on (HK:2190) stock is a Buy with a HK$18.60 price target. To see the full list of analyst forecasts on Zylox-Tonbridge Medical Technology Co., Ltd. Class H stock, see the HK:2190 Stock Forecast page.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. operates in the medical technology industry, focusing on the research, development, and production of medical products. The company is incorporated in the People’s Republic of China and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 632,321
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.5B
See more insights into 2190 stock on TipRanks’ Stock Analysis page.